Kristina Truong
About Kristina Truong
Kristina Truong, age 53, is Senior Vice President and Chief Accounting Officer (principal accounting officer) at Enovix, appointed December 30, 2024, after joining the company in June 2022; she is an active California CPA with a B.S. in Accounting from Capital University and oversees accounting, controllership, financial reporting, and SOX controls . Company performance during her tenure includes 2024 revenue of $23.1 million (vs. $7.6 million in 2023) and a 2024 TSR of 55, indicating significant top-line growth alongside continuing investment; non-GAAP Q4 2024 metrics reported by Enovix included revenue of $9.7 million, EBITDA loss of $11.7 million, and non-GAAP EPS loss of $0.11, with cash and equivalents of ~$273 million .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Spruce Biosciences | Corporate Controller | 2020–Jun 2022 | Led corporate accounting and compliance in a high‑growth environment |
| Outset Medical, Inc. | Corporate Controller | 2018–2020 | Managed corporate controller functions at a public med‑tech company |
External Roles
- No public company directorships disclosed; credential: active California Certified Public Accountant .
Fixed Compensation
- Not disclosed for Ms. Truong in the latest proxy or 8‑K filings; Enovix did not include Ms. Truong among 2024 Named Executive Officers (NEOs), and detailed pay tables cover CEO, COO, CLO, and former CFO .
Performance Compensation
- Not disclosed for Ms. Truong; Enovix’s incentive design (AIP and LTIP with PRSUs/RSUs) is detailed for NEOs, but individual targets/payouts for the CAO are not provided in filings .
Equity Ownership & Alignment
| Ownership Metric | As of | Value | Notes |
|---|---|---|---|
| Total beneficial ownership (shares) | 01/17/2025 | 122,632 | Initial Form 3 filing upon appointment |
| RSUs included in beneficial ownership | 12/30/2024 | 115,200 | “Includes 115,200 shares issuable upon the settlement of RSUs” |
| % of shares outstanding | 04/15/2025 (record date) | ~0.064% (122,632 ÷ 191,970,506) | Derived from Form 3 shares and shares outstanding |
| Pledging/Hedging status | Policy | Company prohibits pledges, short sales, hedging; waivers only by Board/Audit Committee; no Truong waivers disclosed | Rodgers had a pledge waiver; no such disclosure for Truong |
| Stock ownership guidelines | — | Not disclosed | No executive ownership guideline disclosure found for CAO |
Insider activity:
- Initial Form 3 reported above; no Form 4 transactions located in company filings/search to date (Jan–Nov 2025) .
Employment Terms
| Term | Detail |
|---|---|
| Appointment | Appointed Senior VP & Chief Accounting Officer on 12/30/2024; principal accounting officer |
| Company tenure | Joined Enovix in June 2022 |
| Responsibilities | Oversees accounting, controllership, financial reporting, SOX controls; senior leadership role |
| Indemnification | Expected to enter company’s standard indemnification agreement for officers |
| Related parties | No family relationships and no related person transactions disclosed for Truong |
| Insider trading policy | Prohibits short sales, options, hedging, and pledging absent waivers; applies to officers |
| Clawback policy | Executives subject to recoupment of excess incentive compensation after restatements (effective Oct 2, 2023) |
Investment Implications
- Alignment and vesting pressure: Initial ownership comprised largely of RSUs (115,200 of 122,632), indicating multi‑year equity alignment but also potential periodic settlement/vesting events that can add supply when trading windows open; however, no Form 4 sales are observed so far .
- Controls and execution: As principal accounting officer, Truong’s oversight of SOX controls and financial reporting is central to Enovix’s internal control quality; the company notes prior material weaknesses have been remediated and emphasizes retention of key finance talent amid 2024–2025 leadership transitions (CFO departure in Dec 2024, CAO role creation, new CFO in Apr 2025), a factor for retention risk monitoring .
- Company performance context: 2024 revenue scaled to $23.1 million with Q4 beats on revenue and non‑GAAP loss guidance, supporting the narrative of operational progress; cash of ~$273 million provides runway, but continued losses and capex underscore the need for disciplined financial execution under Truong’s remit .
- Governance safeguards: Insider trading restrictions and clawback policy reduce misalignment risk; no pledging disclosure for Truong, which is positive relative to policy red flags .
Note: Specific base salary, bonus targets/payouts, and individual equity award vesting schedules for Ms. Truong are not disclosed in public filings; the equity and incentive design details published apply to the NEO cohort rather than the CAO .